文献速递老年精神

晚年中期可改变痴呆风险因素的潜在剖面:与痴呆发病、认知和神经影像结局的关系

Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes.
PubMed 文献 · Mol Psychiatry · 2024-08-05

该研究基于英国生物银行55,333名男性和63,063名60-64岁无痴呆成人,用潜在类别分析识别出三种性别特异性可改变痴呆风险剖面:心脏代谢风险、物质使用相关风险和低风险。心脏代谢风险剖面在男女中均与全因痴呆发病率升高、认知表现较差、脑萎缩更重和白质高信号体积更大相关。物质使用相关风险剖面在男性中与认知较差和白质高信号更多相关但痴呆发病率无差异,在女性中与痴呆发病率升高和脑萎缩更重但白质高信号体积更小相关。

要点

  • 在60-64岁无痴呆成人中识别出三种性别特异性可改变痴呆风险剖面:心脏代谢风险、物质使用相关风险和低风险。
  • 心脏代谢风险剖面在男女中均与全因痴呆发病率升高相关(男性OR 2.33,女性OR 1.44),并伴认知较差和脑萎缩更重。
  • 物质使用相关风险剖面在男性中与痴呆发病率无差异(OR 1.00),在女性中与痴呆发病率升高相关(OR 1.58)。

核心结论

  • 研究揭示了三种可改变痴呆风险剖面及其独特的认知和神经影像结局,以及它们与阿尔茨海默病遗传风险的交互作用。
  • 这些差异凸显了在风险预测工具和个性化预防策略规划中考虑人群异质性的必要性。

研究设计与样本

  • 研究使用英国生物银行中60-64岁无痴呆成人,共55,333名男性和63,063名女性。
  • 采用潜在类别分析识别可改变痴呆风险因素的剖面,并估计其与痴呆发病、认知和神经影像结局的关联。
  • 研究探索了不同剖面间阿尔茨海默病多基因风险评分对结局影响的差异。

主要发现

  • 在男性和女性中均识别出三种性别特异性潜在剖面:心脏代谢风险、物质使用相关风险和低风险。
  • 心脏代谢风险剖面与低风险剖面相比,男性全因痴呆OR为2.33(95%CI 2.03-2.66),女性OR为1.44(95%CI 1.24-1.68),且认知表现更差、脑萎缩更重、白质高信号体积更大。
  • 男性物质使用相关风险剖面与低风险剖面相比,认知表现更差、白质高信号更多,但全因痴呆发病率无差异(OR 1.00,95%CI 0.95-1.06)。
  • 女性物质使用相关风险剖面与低风险剖面相比,痴呆发病率升高(OR 1.58,95%CI 1.57-1.58)、脑萎缩更重,但白质高信号体积更小。
  • 多基因风险评分在女性中效应更大,且在不同剖面间对结局影响不同;例如男性中心脏代谢风险剖面与低风险剖面相比,多基因风险评分对萎缩的效应更大;女性中心脏代谢风险剖面与低风险剖面相比,多基因风险评分对白质完整性丧失的效应更大。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In 2020, the Lancet Commission identified 12 modifiable factors that increase population-level dementia risk. It is unclear if these risk factors co-occur among individuals in a clinically meaningful way. Using latent class analysis, we identified profiles of modifiable dementia risk factors in dementia-free adults aged 60-64 years from the UK Biobank. We then estimated associations between these profiles with incident dementia, cognition, and neuroimaging outcomes, and explored the differences across profiles in the effects of a polygenic risk score for Alzheimer's disease on outcomes. In 55,333 males and 63,063 females, three sex-specific latent profiles were identified: cardiometabolic risk, substance use-related risk, and low risk. The cardiometabolic risk profile in both males and females was associated with greater incidence of all-cause dementia (male: OR [95% CI] = 2.33 [2.03, 2.66]; female: OR [95% CI] = 1.44 [1.24, 1.68]), poorer cognitive performance, greater brain atrophy, and greater white matter hyperintensity volume compared to the low risk profile. The substance use-related risk profile in males was associated with poorer cognitive performance and greater white matter hyperintensities compared to the low risk profile, but no difference in all-cause dementia incidence was observed (OR [95% CI] = 1.00 [0.95, 1.06]). In females, the substance use-related risk profile demonstrated increased dementia incidence (OR [95% CI] = 1.58 [1.57, 1.58]) and greater brain atrophy but smaller white matter hyperintensity volume compared to the low risk profile. The polygenic risk score had larger effects among females, and differentially influenced outcomes across profiles; for instance, there were larger effects of the polygenic risk score on atrophy in the cardiometabolic profile vs. the low risk profile among males, and larger effects of the polygenic risk score on loss of white matter integrity in the cardiometabolic profile vs. the low risk profile among females. These results reveal three modifiable dementia risk profiles, their unique cognitive/neuroimaging outcomes, and their interactions with genetic risk for Alzheimer's disease. These differences highlight the need to consider population heterogeneity in risk prediction tools and in planning personalized prevention strategies.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Xiong LY, Wood Alexander M, Wong YY, et al. Latent profiles of modifiable dementia risk factors in later midlife: relationships with incident dementia, cognition, and neuroimaging outcomes. Mol Psychiatry. 2024. PMID: 39103532. doi:10.1038/s41380-024-02685-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。